MarketsStocksBAFNAPH
BA

Bafna Pharmaceuticals Ltd

NSE: BAFNAPHBSE: 532989Healthcare
160.31
+5.00%
NSE · 15-min delayed
Prev Close
₹73.15
Day High
₹160.31
Day Low
₹160.31
Mkt Cap
₹312 Cr
P / E
28.1
P / B
3.3
ROE
11.5%
52W High
₹202.06
52W Low
₹72.01
Key Metrics
Market Cap
₹312 Cr
P / E
28.12
P / B
3.25
EV / EBITDA
15.78
ROCE
10.9%
ROE
11.5%
Debt / Equity
0.39
Book Value
₹49.33
EPS
₹4.69
Div Yield
0.0%
Face Value
₹10
Revenue · ₹ Cr
42
FY20
71
FY21
85
FY22
115
FY23
152
FY24
146
FY25
151
FY26
Net Profit · ₹ Cr
-25
FY20
6
FY21
5
FY22
11
FY23
7
FY24
4
FY25
11
FY26
EPS · ₹ per share
₹-15.5
FY20
₹2.5
FY21
₹4.3
FY22
₹4.9
FY23
₹3.1
FY24
₹1.8
FY25
₹4.7
FY26
P / E Ratio · price ÷ TTM EPS
94581117235Jun 21Jan 23Oct 24Jun 26
P/E 34.2×Median 27.2×TTM EPS
Q1 2020 snapshot
Sales
₹13 Cr
Operating profit
₹3 Cr
OPM
25.9%
Net profit
₹0 Cr
EPS
₹0.20
Scorecard · 7 axes
Quality
Good
74/100
Valuation
Avg
28.1×
Growth
Good
+18.2%
Profitability
Avg
11.2%
Performance
Strong
+119.2%
Entry Point
Good
79%
Red Flags
Strong
0 flags
Shareholding Pattern
75.0%Promoter
Promoter75.0%
FII9.3%
Public15.7%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue33.3840.0935.2236.6539.5144
Net Profit0.9481.3113.3893.1251.8372.749
NPM %2.8%3.3%9.6%8.5%4.6%6.2%
AlertPre-trade